SUMMARY
INTRODUCTION
Besides its cosmetic, sexual and psychosocial importance, subcutaneous abdominal fatty tissue is a dominant architectural, but a highly underestimated compartment of the body. It has not only ordinary biological key functions such as thermoregulation, thermoinsulation, physical buffer or energy storage, but also influences on important immune, metabolic, and even brain functions. Indeed, it has newly understood that subcutanous adipocytes have some significant functions such as cytokine and growth factor production, being a big resource for stem cells, and endocrine functions 1 . Since that turning point, neurobiology and molecular medicine specialists concentrated on adipotargeting studies, which clearly showed that the adipose tissue is the largest endocrine/paracrine organ producing many bioactive proteins called adipokines. Owing to these studies, certain diseases such as type 2 diabetes, atherosclerosis or metabolic syndrome (MS) have been associated with increased fatty tissue 2 . Hirsutism (HR) is a multicausal androgenrelated condition. It may be idiopatic or can be resulted from androgen-releasing disorders such as polycystic ovary syndrome (PCOS), neoplasms, hyperthecosis or hyperprolactinemia. However, hyperinsulinaemic androgen excess is accepted as the most common cause of HR, in recent years. Similar to MS, it is thought that HR frequently originates from an absolute or relative excess of lipids in adipose tissue, and from associated changes in insulin sensitivity, gonadotropin secretion and ovarian androgen release 3 . Lack of literature on correlations between the modified Ferriman-Galleway scores (mFGSs) and subcutaneous abdominal fatty tissue thickness (SAFTT), and also MS criteria in women with HR encouraged us to conduct this study.
MATERIAL AND METHODS

Study design and subjects
One hundred and forty hirsute women between the ages of 18-50, years olds included in study from November 2014 to March 2015. It was conducted in our dermatology department as a prospective pilot study. The study was approved by responsible local ethical committee, and was conducted with the understanding and the consent of the human subject. The subjects who under the age of 18 and did not give consent, menopausal and pregnant women, those having known diseases which lead to HR such as congenital adrenal hyperplasia, Cushing syndrome, thyroid dysfunction, androgen secreting tumors, hypercortisolism, hyperprolactinemia, hypertekosis, who had acute disease that can lead respiratory distress, e.g., influenza (because it can prevent deep exhalation), who had known diabetes, heart, pulmonary, gastrointestinal, neurological and neoplastic diseases, who used drugs that interfere with endocrine or lipid metabolism such as sex steroids, thyroid hormones, corticosteroids, anticonvulsants, antiretrovirals, antilipidemics, who used drugs can cause hyperprolactinemia such as risperidone, haloperidol or metoclopramide, those who previously known to be MS, and who underwent any operation or had any scar in the measurement areas were excluded from study. The study was performed in accordance with the Declaration of Helsinki 2013.
Data collection from clinical examinations
After a detailed medical interview, accompanying androgen-dependent other clinical conditions including acne, seborrhea, androgenetic alopecia (AGA), acanthosis nigricans (AN), skin tag, PCOS, and changes in cycle (amenorrhea/oligomenorrhea/polymenorrhea) of subjects were examined and recorded. Later, anthropometric parameters (Weight, body mass index [BMI], waist circumcerence [WC] ), and systolic and diastolic blood pessures (SBP, DBP) of the subjects were measured. Skin findings were diagnosed clinically, and diagnosis of PCOS was made based on the Revised Criteria of Rotterdam (2003) , which require the presence of at least two of the following three features: i) oligo or anovulation (<8 spontaneous hemorrhagic episodes/year);
ii) biochemical hyperandrogenemia (defined in our subjects as early follicular phase-total testosterone (TT) > 0.82 ng/ml) or clinical manifestations of hyperandrogenemia (mFGSscore ≥ 8); and iii) polycystic ovaries on ultrasound (≥12 small follicles in at least one ovary and/or ovarian volume >10 cm3) 4 . BMI was calculated as weight (kilograms) divided by height (square meters) for an estimate of obesity. The evaluation was made as underweight = < 18,5 kg/m2, normal weight =18.5 to 25, overweight=25 to 30, and obese= over 30 5 . WC was measured at the midpoint between the twelfth rib and the iliac crest 6 . SBP and DBP were measured following the JNC-7 guidelines 7 . The diagnosis of HR was done based on clinical examination findings of subjects. Severity of disease was visually determined by the mFGS system, in which the density of terminal hairs is graded at 9 different body sites (i.e., upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, arm, and thigh ). According to the severity of disease, each region can take a score of 0 (absence of terminal hairs) to 4 (extensive terminal hair growth). The evaluation is made as normal,<8; mild, 8-15; moderate, 16-25; and severe, >25 8, 9 . In the examining of MS components and diagnosis of MS, National Cholesterol Education Program Adult Treatment Panel III (ATP III) criteria were used. According to the criteria, subjects who had more than 3 of the following risk factors were diagnosed with MS: levels of fasting glucose, ≥110 mg/dL; fasting triglycerides, ≥ 150 mg/dL; HDL, <50 mg/dL; WC, ≥80 cm; and SBP, ≥130 mmHg; or DBP, ≥85 mmHg 10, 11 .
Laboratory analyzes
Fasting blood samples for all tests including free testosterone (FT) and TT, dehydroepiandrosterone sulphate (DHEAS), androstenedione, 17-hydroxy progesterone (17-OH-PG), SHBG, prolactin, glucose, insulin, glycated hemoglobine (HbA1C), HDL and triglycerides, were taken during follicular phase (cycle days [2] [3] [4] [5] [6] [7] [8] 85-885mg/dl), 2.6-24.9 µIU/ml for insulin (DL: 0.2-1000 µIU/ml), and 4-6% for HbA1C (DL:3-20%). FAI ratio was determined by following formula: [FAI = TT(nmol/l) x 100/SHBG (nmol/l)], using the following converter formula: (1 ng/ml=0.314465 nmol/l), and assesed as normal=<5, and high=≥5 [12, 13] . Insulin resistance (IR)was detected by HOMA-IR, which was calculated as follows: HOMA-IR=fasting insulin (mIU/L) × glucose (mg/dl)/405 [14] , and evaluated as normal=<2,5, and high=≥2,5 [15] .
Ultrasonic measurement of SAFTT
Subcutaneous fatty tissue-USG was performed on fasting subjects by the same operator using a Toshiba Aplio 300 apparatus with a 7.5 MHz linear probe (Toshiba Medical Systems, Tokyo, Japan). SAFTT was measured from 4 different points at distances of 1 cm from the umbilicus (above, below, right and left). It was measured as the distance between the epidermis and the external surface of the rectus abdominis muscle at the end of the maximum exhalation [16] , by applying the same probe pressure to the abdomen of subjects. Each measurement was repeated 3 times, and means of them were used for analysis. The daily intra-operator coefficient of variation for repeated measures of SAFTT in our laboratory was 0.54 %.
Statistical analysis
It was followed through NCSS (Number Cruncher Statistical System, Utah, USA, 2007) software package program. Standart descriptive statistics were expressed as means ± standard deviation (SD). Categorical variables were expressed as percentages (%). The normality assumption of the groups was checked using Kolmogorov Simirnov test. Quantitative data was compared with independent-samples t-test where their distribution was normal, whereas the Mann-Whitney U non-parametric analysis was used for the comparison of group means when the distribution was not normal. Chi-square test was used to compare qualitative data. The significance of differences in means was determined using 95% confidence intervals, and a p value < 0.05 was considered as statistically significant.
RESULTS
One hundred and fourty four women were evaluated. Only moderate and severe HR groups were detected in study population. Mean age of the subjects was 24.47 ±7.52 years. Subgroups and their distribution ratios according to the age, marital status, HR-associated clinical findings, MS components according to the ATP III criteria, number of subjects having 0 to 4 MS criteria and MS are seen in Table 1 . 
71% ǂ Independent-samples t-test, *Mann-Whitney U test, ‡ Chi-square test
Means of weight and BMI, and presence of overweight and obese persons in the severe-mFGS group was significantly higher than those with moderate-mFGS (each p=0.0001). Significantly higher means of insulin (p=0.038), HOMA-IR (p=0.033), and triglyceride (p=0.003), and lower means of HDL (p=0.003) were obtained in the severe-mFGS group, and presence of HDL <50, and triglyceride ≥150 were also higher in the severe-mFGS group (p=0.004 and p=0.039). Both presence of WC≥80 and its means were higher in the group with higher mFGS (each p=0.0001). Presence of higher SBP and DBPs, and their means were significantly higher in severe-mFGS group (each p=0.0001). Having two, three and four MS criteria of subjects, and those who were diagnosed with MS were significantly higher in severe-HR group (each p=0.0001). Comparison of the means of HRrelated laboratory tests and SAFTT values in each region according to the mFGS groups are shown in Table 3 . 9, 17 . It is thought that idiopatic HR results from abnormal/increased sensitivity of hair follicles to normal levels of circulating androgens, especially in non-obese persons as associated with abdominal (android) obesity 9, 18 . Because nearly 50% of the circulating testosterone is derived from peripheral tissues like adipose tissue with the enzymatic conversion of androstenedion in premenopausal women, it is thought that HR must be more common in overweight people 17 . Our all subjects were also premenopausal women, and most of them were owerveight and obese persons. Hyperandrogeniclinked clinical conditions, which are also IRrelated conditions have been described as HR, seborrhea, acne, AGA, AN, skin tag, oligo and amenorrhea 9, 17, 19 . These conditions are usually accompanied by PCOS, which is the most common cause of oligo or anovulatory HR [4, 9, 19] . All of our subjects had PCOS. Patients with PCOS may have acne up to rate of 70%, and oligo or amenorrhea may accompany to them, with a predominancy of oligomenorrhea 4, 9, 17, 20 . Skin tag is frequently seen in AN patients, who can also have PCOS, obesity, MS or impairment of carbohydrate metabolism. AGA and IR/hyperinsulinemia relationship is strongly supported by Matilainen et al. and Bakry et al. They suggested that early onset AGA (<35) could be a clinical marker of IR, and these cases should be assessed for MS components and IR. The role of insulin in hyperandrogenic skin findings of obese females has been explained with 5 -reductase-induction, increased androgen receptor signal transduction, induction of sebum secretion and lipogenesis and keratinocyte-proliferation, by decreased levels of insulin-like growth factor (IGF) receptors and increased local levels of free IGF-1 9, 19 . Our findings were in agreement with above information. Except for the relatively low rates of skin tag (27.08%) and amenorrhea (6.25%), all the subjects had PCOS, and most of them had the other mentioned androgen-related conditions with no significant differences between the mFGS groups. IR-related thoughts on the etiopathogenesis of HR have gradually been increased in recent years, and hyperinsulinaemic androgen excess was accepted the most common cause of especially idiopathic HR 19, 21 . Many studies showed that impaired glucose tolerance and IR may seen in hirsute women with or without PCOS 9, 19 . Hyperinsulinemia and increased IR are accepted as not only the most important cause, but also concequences of obesity and MS, as well. It is suggested that increased insulin leads to gonadotropin-like stimulation on IGF-1 receptors in ovarian techa cells, and results increased androgen production 9, 17, 19 . BMI is the most commonly used method in estimating of obesity, whereas circulating androgens are positively correlated with increased BMI in HR. However, the correlation may not always be valid, and may change depending on the racial/ethnic characteristics of persons. Naeini et al reported significantly higher BMI rates in young Iranian hirsute women compare to healty ones Although our overweight/obese subjects had slight majority over others (52.78% versus 47.22%), significantly higher BMIs were detected in severe-mFGS group. In women with severe IRsyndromes, hyperandrogenemia and PCOS are common findings. Moreover, HR and oligomenorrhea were shown to be the referring signs in several cases of severe IR-syndromes like MS 24 . Sally et al. recommended that patients with HR and especially ones also having PCOS should be evaluated for MS parameters such as BMI, WC, high BP, impaired glucose tolerance and lipid profiles 25 . However, the delevelopment of MS is depended on the etiology of HR, with higher risk for persons with classic PCOS followed by those with ovulatory PCOS and idiopathic hyperandrogenism, and the lowest risk for women with idiopathic HR 9 . Because all of our subjects had oligo or anovulatory PCOS, they were high risk group for MS. However, according to ATP III criteria, above threshold insulin and glucose levels were detected in only rates of 0.02% and 18.06%. Mean insulin values were significantly higher in severe-mFGS group, whereas mean glucose was not different. HOMA-IR is one of the tests used for quantifying IR. Its value ≥2.5 is taken as an indicator for IR in adults 15 . We also detected increased HOMA-IR in 53.47% of total of subjects, in which mean values were significantly higher in severe-mFGS group. Previous reports on relationship between HR and IR give contradictory results in PCOS patients 26 . Because our all subjects had PCOS, but only severe-mFGS group had significantly higher BMIs, the relationship between IR and HR appears to be associated with more severe obesity, independently of PCOS. Indeed, a great majority of our subjects had above thresholds values for low-HDL, high-trygliceride, SBP, DBP and WC, and there were significant differences in terms of MS parameters between the groups, favoring severe-mFGS group. Even if HR had previously been associated with hyperandrogenemia, there is a poor correlation between the severity of HR and excess of androgens. Especially idiopatic HR does not correlate well with amount of androgens. For determining of androgens in HR, most used tests are TT, FT, DHEAS, androstenedion, SHBG, 17-OH-PG and prolactin 9, 27 . Because the difficulties in sensitive determining of FT values, use of FAI index is suggested, and it is accepted as better predictor for hyperandrogenism than testosterone 27 . On the other hand, importance of serum androstenedione and DHEAS in HR diagnosis is unclear, and DHEAS levels may not always reflect the adrenocortical steroidogenesis 9 .
Although TT means of all subjects were within the normal limits, and FAI values were subthreshold (<5) in most subjects, significantly higher values of TT, and significantly different and above threshold FAI means were obtained in severe-mFGS group. From the other side, because high insulin decreases SHBG production in the liver, FT levels increase in plasma 17 . Although SHBG levels of all subjects were within the reference ranges, means of severe-mFGS group were significantly lower. Because oligo/anovulatory PCOS is usually associated with high androgen levels 4, 9, 20 , and our androgen levels were different but below threshold values, different degrees of HR in our subjects might be associated with the differences in IR-related parameters such as BMI, insulin and HOMA-IR. Our results supported the previous reports regarding to have high androgens is not necessary for the development of HR. They also support that subtreshold androgen levels may be enough for excessive stimulation of hair follicles, because MS-related hyperinsulinemic factors provide a susceptibility to the androgens with the help of suppressed SHBG levels in obese women. On the other hand, USG-determined SAFTT measurement is a simple and important method to evaluate the association between BMI/abdominal obesity and MS 28. There is some reports supporting presence of higher SAFTT values in women with PCOS 16, 29 . Wehr et al. showed that increased lower-abdomen and upper-back SAFTTs are associated with IR, impaired glucose tolerance, and an unfavorable lipid profile in these women 29 . However, no study was reported in association between SAFTT and mFGSs. We obtained significantly high values in SAFTT means at each periumblical region, in severemFGS group. Presented findings indicate that increased SAFTT may be a metabotrophic indicator for severity of HR in especially overweight women by creating more androgenproducing areas, as considered in MS and PCOS cases. Because presented study was not controlled and all the subjects had PCOS, we do not yet know whether there is a cutt-off value for SAFTT to be used as an indicator for HR cases, independently of PCOS. Additionally, although relatively small number of subjects and unequal numbers of groups limit our conclusions, because MS were detected 26 times more in severe-MFS group, we also think that HR may be considered as an additional criterion of MS, in especially obese women. Nevertheless, controlled and broadbased further studies are needed to support our results.
CONCLUSION
Women with severe hirsutism are more likely to have a thicker SAFT and also metabolic syndrome than those with lower scores. Thickened SAFT may a simple metabotrophic indicator for preliminary assessment of severity of HR by creating more androgen-producing areas.
